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Cylindrospermopsin (CYN) is a cyanotoxin produced by various cyanobacterial species. 
It is a water soluble zwitterion, stable at extreme temperatures and pH. Despite the main 
route of exposure to CYN is through drinking water and food, there is a lack of data 
concerning its intestinal absorption and the mechanisms implicated.  
The aim of this study was to characterize the mechanisms involved in the intestinal 
absorption of CYN, using Caco-2 human cell line as a model of the intestinal epithelium. 
The results obtained in the present work increases the limited knowledge regarding CYN 
transport across the intestinal epithelium and identifies the paracellular route as an 
important pathway in CYN absorption. A minor carrier-mediated transcellular transport 
has been evidenced. This transport is not affected by low temperatures, suggesting that 
an active mechanism is not involved. Moreover, the transport through the intestinal 
monolayer is H+ and GSH dependent and Na+ independent. The transport 
characteristics elucidated in this study prepare the ground for future studies directed at 
identifying transporters involved in the intestinal absorption of this toxin. 
 





Cylindrospermopsin (CYN) is a cyanotoxin produced by a number of cyanobacterial 
species including Cylindrospermopsis raciborskii (Ohtani et al., 1992), Umezakia natans 
(Terao et al., 1994), Aphanizomenon ovalisporum (Shaw et al., 1999), Raphidiopsis 
curvata (Li et al., 2001), Anabaena bergii (Stüken et al., 2006), Aphanizomenon flos-
aquae (Preussel et al., 2006), and Anabaena lapponica (Bazin et al., 2010). The toxin 
structure consists of a tricyclic guanidine linked to hydroxymethyluracil group (Ohtani et 
al., 1992). CYN is a zwitterion highly water soluble (Sivonen and Jones, 1999), being 
stable to extreme temperatures and pH (Chiswell et al., 1999). Exposure to CYN is likely 
to happen since the 90% of this cyanotoxin is released from cyanobacterial cells to the 
water (Chiswell et al., 1999; Rücker et al., 2007).  
Human can be intoxicated by this cyanotoxin mainly by the oral route through the 
ingestion of contaminated drinking water (Kuiper-Goodman et al., 1999; Gutiérrez-
Praena et al., 2012) and also by food contaminated with CYN (Kittler et al., 2012; 
Gutiérrez-Praena et al., 2013). Two severe human poisoning events have been reported. 
In North Queensland (Australia), a bloom of Cylindrospermopsis raciborskii in a drinking 
water reservoir resulted in human poisoning undergoing damage in liver and kidney 
(Hawkins et al., 1985). Also, in the Brazilian dialysis clinic tragedy in 1996, the presence 
of CYN and microcystins in dialysis water resulted in more than 50 deaths (Carmichael 
et al., 2001). 
Despite the oral route is the main pathway of human exposure to CYN, there is a lack of 
data concerning the intestinal absorption of this cyanotoxin. Regarding the mechanisms 
of transport implicated in the absorption, due to the small size of the molecule, a limited 
passive diffusion has been suggested (Runnegar et al., 2002). In addition, some studies 
have indicated the participation of a facilitated transport mechanism (Froscio et al., 2009) 
and an active transport, the latter making use of bile acid transport systems (Chong et 




attempt to reduce these toxic effects, it is necessary to characterize its intestinal 
absorption. 
The study of the intestinal absorption can be addressed using in vivo or in vitro models. 
However, due to the ease and accuracy of in vitro models, they are extensively used, 
being the most employed the Caco-2 cell line (Rocha et al., 2013). These cells are 
derived from a colon adenocarcinoma which differentiate spontaneously after 14-15 days 
of culture (Calatayud et al., 2011). When Caco-2 cells are differentiated they exhibit 
morphological and functional features of mature enterocytes (Hidalgo et al., 1989), and 
they can even express some transporter also present in the human small intestine 
(Maubon et al., 2007). All these features have converted Caco-2 cells into a suitable 
model for studying the mechanisms of intestinal absorption. Indeed, this model is 
currently used for in vitro study of absorption of pharmaceuticals (Sevin et al., 2013; Nohr 
et al., 2014) and minerals (Ca, Fe, Zn) (Calatayud et al., 2011); however, it is not 
extensively used in the study of absorption and bioavailability of cyanotoxins. The use of 
Caco-2 monolayers has been practically restricted to microcystins (Zeller et al., 2011; 
Henri et al., 2014), and there is only an approach to the evaluation of the intestinal 
permeability of CYN (Fernandez et al., 2014). 
Considering the lack of data in this field, the present work aimed to investigate the 
mechanisms involved in the intestinal absorption of CYN using Caco-2 human cells as a 
model of intestinal epithelium. In order to address this objective, transport assays were 
carried out both in absorptive and secretory directions. It has been evaluated the 
participation of paracellular and transcellular (active or passive) pathways, analysing the 
influence of parameters such as concentration of H+, Na+ and GSH. Taking into account 
the information obtained in these assays and the data from literature, the participation of 
some transporters has also been investigated by means of assays of competitive 





2. Materials and methods 
2.1. Cyanotoxin standard.  
The cyanotoxin cylindrospermopsin standard (purity > 95%) was supplied by Alexis 
Corporation (Lausen, Switzerland). Stock solution of CYN (100 µg/mL) was prepared in 
sterilized milliQ water and maintained at 4oC until analysis.  
 
2.2. Culture of Caco-2 cells.  
Caco-2 cell line, derived from a human colon carcinoma, was acquired from the 
American Type Culture Collection (ATCC® HTB-37, Manassas, VA, USA). Cells were 
cultured in 75 cm2 flasks using Dulbecco’s Modified Eagle Medium (DMEM) with high 
glucose (4.5 g/L) at pH 7.2, supplemented with 10% (v/v) of heat-inactivated fetal bovine 
serum, 1% (v/v) non-essential amino acids, 1 mM sodium pyruvate, 10 mM HEPES (N-
2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid), 100 U/ml of penicillin, 0.1 mg/ml of 
streptomycin and 0.0025 mg/l of amphotericin B (DMEMc); and incubated at 37º C and 
5% flow of CO2. The medium was changed every 2–3 days. When the cell monolayer 
reached 80% confluence, they were detached with a solution of trypsin (0.5 mg/mL) and 
EDTA (ethylene diamine tetraacetic acid, 0.2 mg/mL) and reseeded at a density of 5×104 
cells/cm². The cells were used between passages 21 and 34. All the reagents used were 
acquired from Hyclone (Fisher, Spain). 
For CYN transport assays, Caco-2 cells were seeded on 6-well plates with inserts with 
a polyester membrane (diameter 24 mm, pore size 0.4 µm; Transwell, Corning, Cultex, 
Spain). The porous support of the insert in which Caco-2 cells were seeded separates 
the well into two compartments: apical (upper) and basolateral (lower). The apical (A) 
compartment represents the intestinal lumen and the basolateral (B) compartment the 
serous compartment (blood or lymphatic vessels). The cells were seeded at a density of 
7.5×104 cells/cm² and they were supplemented with 1.5 mL of DMEMc in the apical 




every 2–3 days until cell differentiation was achieved (14-15 days post seeding). The 
formation of Caco-2 monolayers was evaluated during the differentiation by measuring 
transepithelial electrical resistance (TEER) using a Millicell-ERS voltohmmeter (Millipore 
Corp, Madrid, Spain). The cells were considered suitable for the assays when the TEER 
values were greater than 250  cm2. 
 
2.3. Cell viability assays.  
The effect of various concentrations of CYN on the viability of Caco-2 cells was evaluated 
by using sodium resazurin (7-hydroxy-3H-phenoxazin-3-one-10-oxide sodium salt, 
Sigma). The cells were seeded at a density of 2.5×104 cells/cm2 in 24-well plates and 
supplemented with 1 mL of DMEMc. After differentiation took place, cells were exposed 
to various concentrations of CYN (0.8, 2, 5, 10, 20 µg/mL prepared in DMEMc without 
fetal bovine serum) for 24 and 48 h. After exposure, the medium was withdrawn and the 
culture was washed with phosphate buffered saline (PBS, Hyclone). Then 500 µL of 
resazurin solution (10 µg/mL in DMEMc without serum) were added and it was incubated 
for 2 h at 37°C, 5% CO2 and 95% relative humidity. A volume of 100 µL for each condition 
studied was transferred to a 96-well plate and resazurin reduction was measured 
colorimetrically (570 and 600 nm) using a PowerWave HT microplate scanning 
spectrophotometer (BioTek Instruments, USA). 
 
2.4. Transport assay: Calculation of permeability coefficients (Papp).  
The transport assay was performed in Hanks’ balanced salt solution with NaCO3 (HBSS) 
(Hyclone) supplemented with 10 mM of HEPES (pH 7.2). The study was conducted in 
apical-basolateral direction (A-B), absorptive direction, and in the basolateral-apical 
direction (B-A), the secretory one. The standard solutions of CYN (0.8 µg/mL) prepared 
in HBSS-10 mM HEPES were added to the donor compartment (apical or basolateral, 




min), the contents of the acceptor compartment were totally removed and replaced by 
an equal volume of fresh medium. CYN was determined in aliquots of the acceptor 
medium removed at each time and in the donor medium removed at the end of the 
experiment following the protocol described in section 2.12. 
The apparent permeability coefficients (Papp) were calculated by using equation 1. 
Papp = (dC/dt) (Vr/ACo) (Eq.1) 
where: 
dC/dt is the flow (µg/s) determined by the linear slope of the equation that 
governs the variation in the concentrations of CYN, corrected with dilution, 
against time. 
Vr is the volume of the acceptor compartment (2 mL in A-B direction or 1.5 mL 
in B-A direction). 
A is the surface occupied by the cell monolayer (4.67 cm2). 
Co is the initial concentration of CYN in the donor compartment (µg/mL). 
The efflux ratio (Er) was calculated using equation 2, 
Er = Papp(B-A)/Papp(A-B) (Eq. 2) 
where: 
Papp(B-A) is the apparent permeability coefficient in the basolateral-apical 
direction (cm/s). 
Papp(A-B) is the apparent permeability coefficient in the apical-basolateral 
direction (cm/s). 
 
2.5. Study of paracellular transport of CYN.  
The participation of the paracellular pathway in transport of CYN was evaluated by 
modulating the cell junctions in both directions (A-B and B-A). For this purpose, the cell 
monolayer was incubated with 5 mM EDTA in PBS free of Ca2+ and Mg2+ (Hyclone) for 




HBSS free of Ca2+ and Mg2+ (Hyclone) and 50% of HBSS with Ca2+ and Mg2+, both 
supplemented with 10 mM HEPES, was added to the apical compartment. The acceptor 
medium was collected at various times (15, 30, 45, 60 and 120 min) and the 
concentration of CYN was determined in order to evaluate the Papp in both directions 
(equation 1). At the same time, the efficiency of the EDTA in modulating the cell junctions 
was monitored by determining the Papp of Lucifer Yellow (LY) before and after the EDTA 
treatment. LY is a fluorescent compound transported mainly across intercellular junctions 
which evidence the integrity of the monolayer.  
 
2.6. Effect of temperature on transport of CYN.  
The study of CYN transport at 4°C and 37°C was conducted in the A-B and B-A 
directions. For this study, 0.8 µg/mL of CYN prepared in HBSS supplemented with 10 
mM HEPES was added to the donor compartment. At various times (30, 45, 60, 90 and 
120 min), the medium was removed from the acceptor compartment and replaced with 
the same quantity of fresh medium. The concentration of CYN was quantified in the 
aliquots that were removed and the Papp (equation 1) was determined. 
 
2.7. Effect of pH on permeability of CYN.  
The effect of pH on transport of CYN (0.8 µg/mL) in the A-B direction was studied with a 
pH in the acceptor/donor compartments of 5.5/7.2 and then compared with the assays 
previously made at pH 7.2/7.2. The medium at pH 5.5 was prepared with HBSS 
supplemented with 20 mM o-2-(N-morpholine) ethanesulfonic acid (MES, Sigma), 
whereas the medium at pH 7.2 was prepared with HBSS supplemented with 10 mM 
HEPES. At various times (30, 45, 60, 90 and 120 min) the acceptor medium was 






2.8. Influence of Na+ ions and GSH upon transport of CYN.  
The influence of Na+ ions was analyzed in A-B direction. A control medium was prepared 
[10 mM HEPES, 130 mM NaCl (Panreac), 10 mM KCl (Panreac), 1 mM MgSO4 (Sigma), 
5 mM glucose (Panreac) and 1 mM CaCl2 (Panreac)], together with a medium without 
NaCl in which the latter salt was replaced by an equimolar concentration of choline 
chloride [(CH3)3N(Cl)CH2CH2OH, Sigma]. The CYN treatment (0.8 mg/L) was prepared 
in control medium or in medium without NaCl, and was added to the apical compartment 
(1.5 mL). Control medium (2 mL) was added to the basolateral compartment.  
The influence of GSH upon the transport of CYN in the A-B direction was evaluated by 
co-exposing Caco-2 cells to 0.8 mg/L CYN and GSH (Sigma) at various concentrations 
(0.1, 1, 10 mM) prepared in HBSS with 10 mM HEPES.  
After 120 min, apical and basolateral media were collected and the concentration of CYN 
was determined (section 2.12). 
 
2.9. Inhibition studies of CYN transport with taurocholate and L-carnitine.  
The inhibition assays were carried out at pH 7.2 for L-carnitine and at pH 5.5 on the 
apical side for taurocholate. The cell monolayer was preincubated with the corresponding 
inhibitor added to the apical compartment: 0.2mM sodium taurocholate or 0.012 mM L-
carnitine (Sigma, Spain). Then, without eliminating the inhibitor, we added the standard 
solutions of CYN (0.8 mg/L final concentration). At various times (30, 60 and 90 min), 
the medium was removed from the acceptor compartment and replaced with the same 
quantity of fresh medium. The concentration of CYN was quantified in the aliquots that 
were removed and the Papp (equation 1) was determined. 
 
2.10. Monolayer integrity during the transport assays.  
Monolayer integrity was verified by measuring TEER at different times and determining 




concentration of 100 µM to the apical side and the transport to the basolateral side was 
measured at different timepoints during the experiment using a microplate reader 
(PolarSTAR OPTIMA reader, BMG-Labtech, Germany) at an excitation/emission 
wavelength of 485/520 nm. The transport assays were only considered valid if, a) the 
Papp values for LY at the end of the assay were not superior to 2 × 10-7 cm/s, and b) the 
TEER values did not vary by more than 25% from those observed before the beginning 
of the experiment. 
 
2.11. Evaluation of the participation of passive transcellular transport.  
The experiments were performed using parallel artificial membrane permeability assays 
(PAMPA) with Multiscreen® filter 96 well-plates (Millipore, Spain). A 1% (w/v) solution of 
lecithin (Sigma) in dodecane (Merck, Spain) was prepared, sonicated to ensure complete 
dissolution, and carefully added to each donor plate well (5 µL). Immediately after 
application of the lecithin/dodecane solution, 150 μL of CYN (10 mg/L) prepared in 5% 
(v/v) dimethylsulfoxide (DMSO, Sigma) in PBS at pH 7.2 was added to the wells of the 
donor plate. As control verapamil hydrochloride (Sigma) at a concentration of 200 µM 
was used. Receiver plates with 300 µL of 5% DMSO in PBS were then coupled with the 
donor plates, and the resulting plate assemblies were incubated at room temperature 
without agitation for 16 hours in a sealed container with wet paper towels to avoid 
evaporation. 
After incubation, samples from the donor and receptor plates were recovered for analysis 
of CYN contents. The concentrations of verapamil in the acceptor and donor 
compartments were determined using a UV-VIS spectrophotometer (Infinite M200, 
Tecan, Austria) at a wavelength of 279 nm. The permeability coefficient across the 
artificial membrane (Pam) was calculated using the equation described by Sugano et al. 
(2001): 




flux %= (Cac/Cref)  100 
where Vdn is the volume of the donor compartment (0.15 mL), Vac is the volume of the 
acceptor comportment (0.3 mL), Cac is the quantity of CYN in the acceptor well at the end 
of the experiment (ng), Cref is the quantity of CYN added to the donor well (ng), S is the 
membrane area (0.3 cm2), and t is the incubation time (57.600 s). 
 
2.12. Determination of CYN 
The cyanotoxin content was determined by the method described by Guzmán-Guillén et 
al. (2012) with slight modifications avoiding the clean-up procedure. Briefly, 
chromatographic separation was performed using a Perkin-Elmer Series 200 HPLC 
system coupled to an Applied Biosystems QTRAP LC-MS/MS system (Foster City, USA) 
consisting of an hybrid triple quadrupole linear ion trap (QqQLIT) mass spectrometer 
equipped with an electrospray ion source. The analytical column was a Zorbax Sb-Aq 
column (150x2.1 mm) with a particle size of 3.5 µm (Agilent Technologies). The flow rate 
was 0.2 mL min-1. Chromatographic separation was performed using a binary gradient 
consisting of water and methanol with 0.05% trifluoroacetic acid (v/v). The injection 
volume was 20 µl, and the elution profile was 0% methanol (1 min), linear gradient to 
90% methanol (10 min), 90% methanol (5 min), and finally 0% methanol (5 min). 
 
2.13. Statistical analysis.  
All the treatments were performed at least in triplicate. The statistical analysis was done 
using one-way ANOVA with the Tukey HSD post hoc multiple comparison test or using 







In order to set the concentrations to be used in the transport study, a preliminary cell 
viability assay was carried out (section 2.3). Caco-2 cells exposed to up to 20 µg/mL of 
CYN presented viabilities above 95% with respect to non-treated cells (data not shown). 
For the transport assays the concentration selected was 0.8 µg/mL, which was the lowest 
concentration that could be detected analytically without uncertainty. Furthermore, no 
remarkable differences were observed in the TEER and LY permeability values in all the 
assays carried out, therefore the integrity of the monolayer was assured (section 2.10). 
 
3.1. Transport and permeability coefficients in the A-B and B-A directions.  
The results obtained after exposure of Caco-2 differentiated monolayers to CYN over 90 
minutes indicate that CYN is transported in the absorptive direction (A-B) in a lesser 
extent than in the secretory direction (B-A) (Figure 1). Transport of CYN in both cases 
are very limited, only a 1.5% of CYN is transported in A-B direction and 2.6% in B-A 
direction, and a saturable component is not observed. 
The low transport rate is confirmed with the Papp values obtained in both directions. The 
apparent permeability coefficient is a parameter that indicates the rate of transport across 
a cell monolayer. It is very a useful for making comparisons among results obtained in 
various transport conditions, since the values are corrected by the surface of the 
monolayer, the exposure time and the concentration of the compound (Rocha et al., 
2013). Papp in A-B direction is 3.45 x 10-7 cm/s, whereas the coefficient in the secretory 
direction is slightly greater, 6.41 x 10-7 cm/s. The efflux ratio is greater than the unity, 
1.86 ± 0.14. This corroborates that elimination of CYN towards the lumen (B-A direction) 
is favoured with respect to absorption (A-B direction), as the transport curves (Figure 1) 
and the Papp indicate. According to Hubatsch et al. (2007), efflux ratios higher than 1.5 
suggest the participation of active secretory mechanisms.  
 




The effect of altering the intercellular junctions upon the permeability of a compound is 
used to determine participation of the paracellular route (Gan et al., 1993). If the 
permeability of a given solute increases significantly upon opening the intercellular 
junctions, then the paracellular route is considered relevant in its uptake. In the present 
study, EDTA, a calcium chelator, was added in order to modify the cell junctions. Figure 
2 shows Papp values of CYN in the A-B and B-A directions when Caco-2 cells are treated 
with EDTA and before this treatment. The treatment with EDTA produces considerable 
opening of cell junctions, which has been confirmed by the raise in Papp of LY (increase 
of 32 ± 5%) and the reduction in TEER values (decrease of 83 ± 4%). Opening of 
intercellular junctions significantly increases CYN permeability in both directions, about 
10 times in absorptive direction and around 0.7 times in secretory direction. These results 
clearly indicate that the paracellular pathway is involved in transport of CYN, especially 
in the process of absorption from the lumen (A-B direction). 
 
3.3. Influence of temperature on permeability of CYN.  
Energy-dependent cell processes are minimized at 0-4ºC, and therefore a decrease in 
transport on lowering the temperature may be indicative of the participation of active 
transport. No significant changes are observed in the permeability coefficient in A-B 
direction obtained at 4°C (3.45 ± 0.6 ×10–7 cm/s) in comparison to the values obtained 
at 37°C (4.20 ± 0.05 ×10–7 cm/s) (Figure 3). This finding suggests that no energy-
dependent transport is involved in the process of absorption of CYN or that it is not 
relevant. However, in the B-A direction a significant reduction in transport at 4ºC is 
observed (Papp= 5.02 ± 0.5 ×10–7 cm/s) when compared to the permeability coefficient 
achieved at 37ºC (Papp=6.41 ± 0.2 ×10–7 cm/s) (Figure 3). A possible participation of 
energy-dependent carrier in the secretory direction is expected, which confirms the result 





3.4. Effect of pH on permeability of CYN.  
Throughout the intestinal tract pH varies depending on the section of the intestine 
(Nugent et al., 2001). The influence of an acidic pH in the apical compartment in the 
transport of CYN in A-B direction is shown in Figure 4. The transport of CYN significantly 
increases at pH 5.5 in comparison to a neutral pH in both compartments (7.2/7.2). The 
influence of pH on the transport in the gastrointestinal tract may be due to various 
causes. First, the absorption by passive diffusion depends on the fraction of a compound 
presents in non-dissociated form (Kristl, 2009). If the variations in pH affect the ionization 
state, the transport could be modified. This is not the case of CYN, that it is a zwitterion 
in the range of pHs of the small intestine (5.5-7). Moreover, there are transporters that 
depend on the proton concentration; this could be the reason for the increased transport 
of CYN at acidic pHs, the participation of a H+ dependent carrier. 
 
3.5. Influence of GSH and Na+ ions upon transport of CYN.  
The presence of GSH and Na+ has been pointed out as a driving force for some 
transporters which has been pointed out in the scientific literature that may participate in 
CYN uptake.The influence of GSH in the transport of CYN is represented in Figure 5. 
The results show that the presence of GSH in the apical medium significantly enhances 
the transport of CYN in comparison to the control without GSH. A concentration-
dependent increase in the transport of CYN when Caco-2 cells are co-exposed with GSH 
is observed.  
Regarding the influence of Na+ ions, the absence of Na+ does not decrease the transport 
of CYN in A-B direction, indicating the absence of a Na+ dependent transport mechanism 
(data not show).  
 




These two compounds have been evaluated in order to determine whether their 
presence reduces the A-B passage of CYN, by competition for the same transport 
mechanisms. Taurocholate is transported by bile salts carriers, previously suggested as 
possible carriers of CYN (Chong et al., 2002). Meanwhile, L-carnitine is a substrate of 
the organic cation/zwitterion transporters OCTN (Koepsell, 2013), which transport 
zwitterions as CYN.    
Pre-incubation with these two compounds and posterior co-exposure with CYN does not 
lead to modifications on the permeability coefficients of the cyanotoxin with respect to 
the cells not treated with these inhibitors (data not shown). These results suggest that 
transport of CYN through this type of transporters does not occur or it is marginal. 
 
3.7. Evaluation of transcellular passive diffusion of CYN (PAMPA). 
This assay uses an artificial membrane made of lecithin and dodecane, which allows 
identifying the participation of a transcellular passive transport since carrier-mediated 
and paracellular transport are absent (Sugano et al, 2010). Hence, PAMPA shows trends 
in the ability of a compound to permeate membranes through passive diffusion (Kansy 
et al., 1998). The flow values for verapamil, a lipophilic compound that crosses cell 
membranes mainly through passive diffusion, are high (64.5 ± 2.9%); however, CYN flow 
values are negligible (data not shown), as might be expected given its hydrophilic 
character. Therefore, we can conclude that this cyanotoxin does not cross the membrane 
by simple diffusion through the lipid bilayer or the contribution of this transport 
mechanism is irrelevant. 
 
4. Discussion 
Intestinal absorption plays an important role in the toxicity of contaminants exhibiting the 
oral pathway as the major route of entry into the body, as instance CYN. Therefore, 




for a better understanding of risks that these compounds can exert after intake. In order 
to explore the intestinal uptake of compounds, in vitro studies provide an interesting 
alternative to in vivo studies (Calatayud et al., 2011). There are several studies that 
correlate data of apparent permeability coefficients obtained in vitro using Caco-2 cell 
model with the human intestinal absorption rate (Artursson and Karlsson, 1991; Yee, 
1997). Hence, the evaluation of this parameter can provide us preliminary information of 
what might be occurring in vivo, although in many cases, extrapolation is difficult (Tavelin 
et al., 2003). 
According to Yee (1997), Papp < 1×10-6 cm/s in Caco-2 cells indicates a low in vivo 
absorption (0-20%), Papp between 1-10×10-6 cm/s suggests a moderate absorption (20-
70%), and Papp > 10×10-6 cm/s reveals a high in vivo absorption (70-100%). Comparing 
the results obtained in the present work for CYN in the A-B direction using Caco-2 cells, 
the absorption in vivo would be generally low (<20%). This fact corroborates the results 
obtained previously by Fernández et al. (2014) using the same cellular model, reporting 
a limited passage of the toxin through the intact intestinal epithelium. Since no 
toxicokinetic data performed on laboratory animals is available, the results obtained in 
the present work cannot be compared with any in vivo data.  
Solute transport through the intestinal epithelium can occur by two pathways: 
transcellular or paracellular through intercellular junctions. Paracellular transport 
involves only passive diffusion mechanism, whereas transcellular transport can be 
mediated by passive, facilitated or active processes (Sugano et al., 2010). The studies 
performed in the present study show a significant increase in the permeability of CYN 
with the opening of intercellular junctions, especially in absorptive direction, indicating 
that this toxin is transported by paracellular pathway. The increases in the transport of 
CYN observed after opening the paracellular passage are similar or higher to those 
observed for LY, compound mainly transported through this route. This finding suggests 




This would also explain why the values of Papp of CYN in absorptive direction deduced 
using Caco-2 cells are low. The monolayer formed by Caco-2 cells has tighter cell 
junctions than those in the human small intestine (Tavelin et al., 2003), and therefore it 
may not be the best model for studying the bioavailability of substances that move 
paracellularly, since underestimation of the intestinal transport could be observed. 
Besides the paracellular transport, a transcellular pathway could also participate in CYN 
transport. The evaluation of the possible participation of transcellular transport by 
passive diffusion using artificial lipid membranes shows that this type of transport does 
not occur or is negligible (section 3.7). This was an expected finding considering the 
hydrophilic nature of this cyanotoxin. In the case of the transcellular transport mediated 
by carrier (active or facilitated), initially the assays were focused on the assessment of 
the participation of active transport mechanisms. Low temperatures applied to cellular 
systems are considered general inhibitors of metabolism and ATP generation, and 
hence, of active transport (Calatayud et al., 2011). The study of CYN transport at low 
temperatures shows differences with respect to the data obtained at 37° C only in 
secretory direction (B-A) (Figure 3), suggesting the possible involvement of a 
transcellular transport energy-dependent in this direction, a fact that corroborates the 
deductions derived from the efflux ratio analysis (section 3.1). However, the data do not 
support the presence of an active transport in absorptive direction, which could be 
involved in CYN transport but in a limited extent. 
Chong et al (2002) suggested that CYN and bile acids share transport mechanisms since 
primary cells of murine liver showed lower cytotoxicity to CYN when co-exposed with bile 
acids, taurocholate and cholate. In the intestine, particularly in the apical membrane of 
the small intestine, there are several bile acid transporters: ASBT (SLC10A2) and 
different isoforms of OATP transporter family (Trauner and Boyer, 2002; Alrefai and Gill, 
2007). The ASBT transporters participate in a sodium-dependent transport of bile salts 




of CYN (section 3.5, data not shown), which could discard the participation of ASBT in 
the uptake of CYN through the apical domain. 
Concerning OATPs, several isoforms have been described in the apical membrane of 
the intestinal epithelium: OATP1A2 or OATP-A and OATP2B1 or OATP-B (Roth et al., 
2012). This family of carriers performs a transport ATP- and Na+-independent (Roth et 
al., 2012). Some studies has reported the influence of GSH in the transport mediated by 
these carries. Physiologic GSH efflux stimulates OATP1-mediated substrate uptake into 
hepatocytes as well as into choroid plexus epithelial cells (Gao et al., 1999). Similar to 
OAPT1, OATP2-mediated taurocholate transport was stimulated by high intracellular 
GSH concentrations (Li et al., 2000). Furthermore, the optimum pH for the activity of 
OATP-B is around 5-5.5 (Kobayashi et al., 2003), is a H+-dependent transporter. Our 
results show that this type of transport (independent of Na+ and ATP, and dependent of 
H+ and GSH) could participate in the transport of CYN from the apical side. However, the 
participation of this carrier was not evidenced in the assays performed with taurocholate, 
substrate with high affinity for OATPB (Hagenbuch and Meier, 2003), since the presence 
of this bile acid does not reduce the permeability of CYN at acid pHs.  
Furthermore, Chong et al. (2002) showed that the protective effect of bile salts from CYN 
exposures was in a lesser extent than those observed for other toxins such as 
microcystin and lophyrotomin. Based on these results, the latter authors suggested that 
in addition to bile salts transporters, other mechanisms of transport of CYN may exist. It 
should be highlighted that CYN is a zwitterion and could enter the cell through the specific 
transporters for such molecules. The organic cation/zwitterion transporters (OCTNs) 
operate as uniporters which mediate facilitated diffusion or as Na+/zwitterion 
cotransporters (Koepsell, 2013). Again, Na+-dependent transport is discarded and the 
possibility of a facilitated transport mediated by OCTN rises. In the apical membrane of 
the intestinal epithelium the presence of various isoforms of OCTNs (OCTN1 and 




carnitine. The inhibition studies using this substrate do not reduce the A-B transport of 
CYN; therefore these carriers cannot be pointed as CYN transporters from the apical to 
basolateral side. 
Summarising all the data obtained in the present work, CYN transport in absorptive (A-
B) and secretory (B-A) directions using Caco-2 as a model of intestinal epithelium is 
reduced. Paracellular passive diffusion is predominant in apical-basolateral direction. In 
the secretory transport the involvement of active transport (P-glicoprotein, multidrug 
resistance proteins) seems to be likely, although an important role of the paracellular 
pathway have also been evidenced. The characteristics of the cell model, reduced 
paracellular space and high levels of expression of P-glycoprotein, may be in part the 
reason of the low transport observed from the apical to the basolateral side. Further 
studies could be desirable using models with greater pore diameter in the intercellular 
space and with an expression level of efflux proteins closer to that of the human intestine, 
such as co-cultures Caco-2/HT29-MTX (Hilgendorf et al., 2000) or monocultures of 
NCM-460 (Sahi et al., 1998). In vivo assays are also needed to confirm the results 
derived from cell lines and to select the most suitable in vitro models for further studies.  
Regarding the mechanisms of transport, in addition to the paracellular transport, a minor 
transcellular transport has been evidenced in the apical-basolateral direction which could 
be H+ and GSH-dependent, facilitated (not dependent on energy) and Na+-independent. 
The attempts made to target a specific transporter (bile salts or zwitterions carriers) have 
been unsuccessful, possibly due to the accentuated paracellular route. The identification 
of transporters responsible of the transcellular passage of CYN may require other 
approaches, such as the use of Xenopus laevis oocytes microinjected or overexpression 
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Figure 1. Apical-basolateral (A-B) (♦) and basolateral-apical (B-A) (■) transport of 0.8 
mg/L of CYN in Caco-2 cells as a function of time. Values expressed as ng of CYN/mg 
protein (mean ± standard deviation, n = 3). 
Figure 2. Apparent permeability coefficients (Papp, 120 minutes) of CYN (0.8 mg/L) in 
apical-basolateral n (A-B) and basolateral-apical direction (B-A) in Caco-2 cells 
previously treated with EDTA (grey bars) or without previous treatment with EDTA (white 
bars). Values expressed as cm/s (mean ± standard deviation, n = 3). Significant 
differences with respect to the control (without EDTA) are marked with an asterisk (*) (p 
< 0.05). 
Figure 3. Apparent permeability coefficients (Papp, 120 minutes) of CYN (0.8 mg/L) in 
apical-basolateral (A-B) and basolateral-apical direction (B-A) in Caco-2 cells cultured at 
37ºC (white bars) or 4 ºC (black bars). Values expressed as cm/s (mean ± standard 
deviation, n = 3). Significant differences of assays made at 4ºC with respect to those 
performed at 37ºC are marked with an asterisk (*) (p < 0.05). 
Figure 4. Transport of CYN in the apical-basolateral direction in Caco-2 cells exposed 
to 0.8 mg/L of CYN over 120 minutes at various pHs. Values expressed as ng of CYN/mg 
protein (mean ± standard deviation, n = 3). Significant differences of assays made at pH 
apical/basolateral 5.5/7.2 with respect to the control (pH 7.2/7.2) are marked with an 
asterisk (*) (p < 0.05). 
Figure 5. Transport of CYN in the apical-basolateral direction in Caco-2 cells exposed 
to 0.8 mg/L of CYN over 120 minutes in various conditions: CYN alone (white bar); co-
exposure to CYN and 0.1 mM GSH (black bar); and co-exposure to CYN and 10 mM 
GSH (grey bar). Values expressed as ng of CYN/mg protein (mean ± standard deviation, 
n = 3). Significant differences with respect to the control (without GSH) are marked with 
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